Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
New York Genome Center | RCV001837212 | SCV002097701 | uncertain significance | Neurodevelopmental disorder | 2021-01-21 | criteria provided, single submitter | clinical testing | The inherited heterozygous c.5963T>C (p.Met1988Thr) variant identified in the ANK2 gene has not been reported in affected individuals in the literature. The variant is absent from the gnomAD(V3) database indicating it is an extremelyrare variant in the populations represented in that database. The variant affects an evolutionarily conserved residue and is predicted deleterious by multiple in silico prediction tools. Giventhe lack of compelling evidence for its pathogenicity, the inheritedc.5963T>C (p.Met1988Thr) variant identified in the ANK2 gene is reported here as a variant of uncertain significance. |
Gene |
RCV003163979 | SCV003914878 | uncertain significance | not provided | 2022-10-04 | criteria provided, single submitter | clinical testing | Reported in an individual with arrhythmogenic right ventricular cardiomyopathy in published literature (Roberts et al., 2019); Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 31264976) |